Apollon Wealth Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1764387
MOUNT PLEASANT, SC
Position in REGN
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$2,959,983
+$206,723 QoQ
Shares Held
3,831
+7.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Apollon Wealth Management, LLC holds $22,162,227 across 13 Biotechnology names. REGN ranks #2 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,595 | $17,234,211 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,831 | $2,959,983 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
7,339 | $500,006 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
7,807 | $371,378 | |
| 5 | MRNA |
Moderna, Inc.
|
6,842 | $347,573 | |
| 6 | HURA |
TuHURA Biosciences, Inc./NV
|
158,010 | $282,837 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
767 | $253,777 | |
| 8 | FLNA |
Filana Therapeutics, Inc.
|
35,053 | $59,239 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,959,983 | 3,831 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $2,753,260 | 3,567 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,947,141 | 3,463 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,757,700 | 3,348 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,215,999 | 3,494 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,226,632 | 1,722 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,673,574 | 1,592 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,760,475 | 1,675 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,641,045 | 1,705 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,130,359 | 1,287 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $800,740 | 973 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $654,589 | 911 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $624,469 | 760 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $577,192 | 800 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $938,240 | 1,362 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $740,094 | 1,252 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $921,914 | 1,320 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $852,552 | 1,350 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $738,319 | 1,220 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $821,612 | 1,471 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $846,447 | 1,789 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $9,978 | 16 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||